Allurion Technologies Inc.

$ALUR shares are surging today and leading the Prism MarketView Weight Loss index after Allurion has revealed plans for a clinical study evaluating its weight loss program in combination with glucagon-like peptide-1 receptor agonists (GLP-1RAs)

Share this article:

About the Author:

Allurion Technologies Inc.

Joey Ramson

PRISM Market View Alerts

Get your dose of PRISM Market
View news, right in your inbox

Mailchimp Signup